EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Differential immunologic response to GnRHa alone vs. dual trigger for final follicular maturation: a proof-of-concept pilot study

Raoul Orvieto, Helly Vernitsky, Marina Safanaiev, Dolly Yuster, Dan Dominissini

Frontiers in Reproductive Health · 10.07.2026 · 8

DOI: 10.3389/frph.2026.1890241 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Reproductive Health, online erschienen am 10.07.2026. Verfasst von Raoul Orvieto und 4 weiteren Autor:innen. Beteiligte Einrichtung: Infertility and IVF Unit, Department of Obstetrics and Gynecology, Chaim Sheba Medical Center, Gray Faculty of Medical and Health Science, Tel Aviv U…. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To explore the impact of GnRH agonist (GnRHa) vs. dual trigger (GnRHa plus hCG) for final follicular maturation on peripheral immune profiles in women undergoing oocyte cryopreservation.

Design

Prospective proof-of-concept hypothesis-generating pilot study.

Setting

University-affiliated single center. Patients Five healthy women undergoing fertility preservation ( n = 3 GnRHa trigger, n = 2 dual trigger). Intervention(s) Ovarian stimulation with either GnRHa alone or dual trigger (GnRHa + hCG). Immune profiling was performed at two time points: (1) before trigger, and (2) on the day of oocyte retrieval. Main outcome measure(s) Percent change (%Δ) in peripheral immune blood T, B, and NK cell populations using flow cytometry. Result(s) Baseline characteristics were similar. Compared with GnRHa alone, dual trigger was associated with a trend toward lower CD4/CD8 (helper/cytotoxic) T cell ratio, and an apparent increase in highly differentiated cytotoxic (CD57+) cell populations. However, given the small sample size, findings should not be interpreted as definitive but as exploratory trends. There were no cases of OHSS. Conclusion(s) In this small, exploratory hypothesis-generating study, the addition of hCG to GnRHa trigger was associated with a shift toward a more cytotoxic lymphocyte profile post trigger. Findings require validation in larger, randomized cohorts to better understand their implications for reproductive outcomes and OHSS risk.

Schlagwörter

Stichwörter der Autor:innen

GnRHaOHSSdual triggerflow cytometryhCGimmunologic response

Autor:innen und Institutionen

  • Infertility and IVF Unit, Department of Obstetrics and Gynecology, Chaim Sheba Medical Center, Gray Faculty of Medical and Health Science, Tel Aviv University, Tel-Aviv, Israel.
  • The Tarnesby-Tarnowski Chair for Family Planning and Fertility Regulation, at the Gray Faculty of Medical and Health Science, Tel-Aviv University, Tel Aviv, Israel.
  • Hematology Laboratory, Sheba Medical Center, Ramat-Gan, Israel.
  • Cancer Research Center and Wohl Institute for Translational Medicine, Ramat Gan, Israel.

Zitieren

APA

Orvieto, R., Vernitsky, H., Safanaiev, M., Yuster, D., & Dominissini, D. (2026). Differential immunologic response to GnRHa alone vs. dual trigger for final follicular maturation: a proof-of-concept pilot study. Frontiers in Reproductive Health, 8. https://doi.org/10.3389/frph.2026.1890241

Vancouver

Orvieto R, Vernitsky H, Safanaiev M, Yuster D, Dominissini D. Differential immunologic response to GnRHa alone vs. dual trigger for final follicular maturation: a proof-of-concept pilot study. Frontiers in Reproductive Health. 2026;8. doi:10.3389/frph.2026.1890241

BibTeX
@article{Orvieto2026,
  author = {Orvieto, Raoul and Vernitsky, Helly and Safanaiev, Marina and Yuster, Dolly and Dominissini, Dan},
  title = {Differential immunologic response to GnRHa alone vs. dual trigger for final follicular maturation: a proof-of-concept pilot study},
  journal = {Frontiers in Reproductive Health},
  year = {2026},
  volume = {8},
  doi = {10.3389/frph.2026.1890241}
}
Kostenlos starten →